Terms: = Endocrine gland cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Prognosis
42 results:
1. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
2. Immunohistochemical FAP Expression Reflects
Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
[TBL] [Abstract] [Full Text] [Related]
3. Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer.
Khojasteh-Leylakoohi F; Mohit R; Khalili-Tanha N; Asadnia A; Naderi H; Pourali G; Yousefli Z; Khalili-Tanha G; Khazaei M; Maftooh M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Shahidsales S; Lam AK; Giovannetti E; Nazari E; Batra J; Avan A
Sci Rep; 2023 Oct; 13(1):16678. PubMed ID: 37794108
[TBL] [Abstract] [Full Text] [Related]
4. Methylation-Mediated Silencing of ATF3 Promotes Thyroid cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.
Xiao X; Chen M; Sang Y; Xue J; Jiang K; Chen Y; Zhang L; Yu S; Lv W; Li Y; Liu R; Xiao H
Thyroid; 2023 Dec; 33(12):1441-1454. PubMed ID: 37742107
[No Abstract] [Full Text] [Related]
5. The added value of [
Liu Q; Shi S; Liu S; Xu X; Hu S; Zhang J; Wang C; Yu X; Song S
Eur Radiol; 2023 Jul; 33(7):5007-5016. PubMed ID: 36809431
[TBL] [Abstract] [Full Text] [Related]
6. 18-Fluoride fluorodeoxyglucose positron emission tomography is impactful in newly diagnosed pancreatic adenocarcinoma.
Power J; Larcos G
ANZ J Surg; 2023 Jan; 93(1-2):145-150. PubMed ID: 36582048
[TBL] [Abstract] [Full Text] [Related]
7. Higher SUV
Wrenn SM; Moore AL; Shah HJ; Barletta JA; Vaidya A; Kilbridge KL; Doherty GM; Jacene HA; Nehs MA
Am J Surg; 2023 Feb; 225(2):309-314. PubMed ID: 36137821
[TBL] [Abstract] [Full Text] [Related]
8. The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review.
Evangelista L; Zucchetta P; Moletta L; Serafini S; Cassarino G; Pegoraro N; Bergamo F; Sperti C; Cecchin D
Ann Nucl Med; 2021 Jul; 35(7):767-776. PubMed ID: 34047926
[TBL] [Abstract] [Full Text] [Related]
9. Expression of TIGAR and its correlation with clinicopathology, prognosis, and 18F-FDG PET/CT parameters in patients with resectable pancreatic ductal adenocarcinoma.
Song Y; Wang PY; Zheng Y; Liu C; Wang XM
Nucl Med Commun; 2021 May; 42(5):528-534. PubMed ID: 33481504
[TBL] [Abstract] [Full Text] [Related]
10. Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.
Lasolle H; Elsensohn MH; Wierinckx A; Alix E; Bonnefille C; Vasiljevic A; Cortet C; Decoudier B; Sturm N; Gaillard S; Ferrière A; Roy P; Jouanneau E; Bertolino P; Bardel C; Sanlaville D; Raverot G
Acta Neuropathol Commun; 2020 Nov; 8(1):190. PubMed ID: 33168091
[TBL] [Abstract] [Full Text] [Related]
11. A single-center observational study assessing the predictive factors associated with the prognosis of acromegaly.
Diri H; Ozaslan E; Kurtsoy A; Bayram F
Growth Horm IGF Res; 2020 Dec; 55():101342. PubMed ID: 32916586
[TBL] [Abstract] [Full Text] [Related]
12. Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma.
Yamazaki H; Sugino K; Matsuzu K; Masaki C; Akaishi J; Hames K; Tomoda C; Suzuki A; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Masuda M; Ito K
Endocrine; 2020 Oct; 70(1):115-122. PubMed ID: 32307657
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of
Mohamed E; Needham A; Psarelli E; Carroll M; Vinjamuri S; Sanghera B; Wong WL; Halloran C; Ghaneh P
Eur J Surg Oncol; 2020 Aug; 46(8):1532-1538. PubMed ID: 32070641
[TBL] [Abstract] [Full Text] [Related]
14. Lung recurrence and its therapeutic strategy in patients with pancreatic cancer.
Kurahara H; Maemura K; Mataki Y; Tanoue K; Iino S; Kawasaki Y; Idichi T; Arigami T; Mori S; Shinden Y; Higashi M; Ueno S; Shinchi H; Natsugoe S
Pancreatology; 2020 Jan; 20(1):89-94. PubMed ID: 31787525
[TBL] [Abstract] [Full Text] [Related]
15. Apparent diffusion coefficient-based histogram analysis differentiates histological subtypes of periampullary adenocarcinoma.
Lu JY; Yu H; Zou XL; Li Z; Hu XM; Shen YQ; Hu DY
World J Gastroenterol; 2019 Oct; 25(40):6116-6128. PubMed ID: 31686767
[TBL] [Abstract] [Full Text] [Related]
16. Significance of
Kurahara H; Maemura K; Mataki Y; Sakoda M; Iino S; Kawasaki Y; Arigami T; Mori S; Kijima Y; Ueno S; Shinchi H; Natsugoe S
Ann Surg Oncol; 2019 Feb; 26(2):644-651. PubMed ID: 30523468
[TBL] [Abstract] [Full Text] [Related]
17. A nomogram for predicting survival of patients with locally advanced pancreatic cancer treated with chemoradiotherapy.
Choi SH; Park SW; Seong J
Radiother Oncol; 2018 Nov; 129(2):340-346. PubMed ID: 30177371
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer.
Omiya Y; Ichikawa S; Satoh Y; Motosugi U; Nakajima N; Onishi H
Abdom Radiol (NY); 2018 Dec; 43(12):3381-3389. PubMed ID: 30043215
[TBL] [Abstract] [Full Text] [Related]
19. What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.
Andrade MO; Cunha VSD; Oliveira DC; Moraes OL; Lofrano-Porto A
Arch Endocrinol Metab; 2018; 62(2):264-269. PubMed ID: 29768630
[TBL] [Abstract] [Full Text] [Related]
20. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.
Ghaneh P; Hanson R; Titman A; Lancaster G; Plumpton C; Lloyd-Williams H; Yeo ST; Edwards RT; Johnson C; Abu Hilal M; Higginson AP; Armstrong T; Smith A; Scarsbrook A; McKay C; Carter R; Sutcliffe RP; Bramhall S; Kocher HM; Cunningham D; Pereira SP; Davidson B; Chang D; Khan S; Zealley I; Sarker D; Al Sarireh B; Charnley R; Lobo D; Nicolson M; Halloran C; Raraty M; Sutton R; Vinjamuri S; Evans J; Campbell F; Deeks J; Sanghera B; Wong WL; Neoptolemos JP
Health Technol Assess; 2018 Feb; 22(7):1-114. PubMed ID: 29402376
[TBL] [Abstract] [Full Text] [Related]
[Next]
